Signaturefd LLC Purchases 6,048 Shares of CVS Health Corporation (NYSE:CVS)

Signaturefd LLC increased its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 43.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,923 shares of the pharmacy operator's stock after buying an additional 6,048 shares during the period. Signaturefd LLC's holdings in CVS Health were worth $1,350,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. McIlrath & Eck LLC increased its stake in shares of CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares during the last quarter. Park Square Financial Group LLC acquired a new stake in shares of CVS Health in the 4th quarter worth $43,000. PARK CIRCLE Co increased its stake in shares of CVS Health by 42.9% in the 4th quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock worth $45,000 after acquiring an additional 300 shares during the last quarter. Strategic Investment Solutions Inc. IL increased its stake in shares of CVS Health by 77.2% in the 4th quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator's stock worth $46,000 after acquiring an additional 446 shares during the last quarter. Finally, Ball & Co Wealth Management Inc. acquired a new stake in shares of CVS Health in the 4th quarter worth $49,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Cowen reiterated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Mizuho raised their target price on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Royal Bank Of Canada raised their target price on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a report on Monday, May 5th. Finally, Robert W. Baird lifted their price objective on CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $75.06.

Insider Activity

In related news, Director Guy P. Sansone acquired 1,570 shares of CVS Health stock in a transaction dated Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director directly owned 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.22% of the company's stock.

CVS Health Stock Down 2.1%

CVS traded down $1.36 on Friday, reaching $61.94. The company's stock had a trading volume of 8,610,279 shares, compared to its average volume of 10,760,597. The stock has a market cap of $78.36 billion, a price-to-earnings ratio of 14.78, a price-to-earnings-growth ratio of 0.91 and a beta of 0.57. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $72.51. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. The business's 50 day moving average is $64.70 and its 200 day moving average is $62.88.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. CVS Health's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.31 EPS. As a group, research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.29%. The ex-dividend date is Tuesday, July 22nd. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.